Navigation Links
Gq-coupled Receptor Assays Using FLEXstation

e Set Up
The assay parameters were as follows:

1. Wavelengths: The samples were excited at 485 nm, and emission was detected at 525 nm with a 515 nm cutoff filter.

2. Sensitivity: The number of reads/well was set to 6, and PMT was set to high.

3. Timing: Samples were read at 1.52 second intervals for 120 seconds (total of 79 reads/well).

4. Autocalibrate: On

5. Compound transfer: The pipettor height was set to 220 L to transfer a volume of 50 L at a rate of 4 (corresponds to a rate of 64 L/second). Compound transfer was started after 16 seconds of background reading.


RESULTS

The average EC50 value obtained with the FLEXstation Calcium Assay Kit and the FLEXstation was 47 mM (Figs. 3, 4). The values varied by less than twofold for experiments performed on the same day and by less than fourfold for experiments performed on different days. The range of values from all experiments was between 24 and 87 mM. The coefficient of variation of replicate samples within an experiment varied from 5.6 to 13.8% (average 8.6%) for the 1 mM ADP concentration.

Furthermore, the EC50 value obtained with the fluorescence-based whole cell method (47 M) compared favorably to the EC50 value obtained by measuring [3H]IP (~190 M). Thus, the assay is highly reproducible within and between experiments as well as between assay types (IP and calcium accumulation).



CONCLUSIONS
FLEXstation can be used to assess the specificity and sensitivity of Gq-coupled receptors for different ligands and drugs that are meant to target these receptors. Specifically, FLEXstation and SOFTmax PRO software provide easy experimental set-up, gathering of data
'"/>

Source:


Page: All 1 2 3 4 5 6 7

Related biology technology :

1. Gq-coupled receptor assays using FLEXstation: M1 muscarinic receptor
2. Gq-coupled receptor assays: a comparison of FLEXstation and FLIPR
3. Antibodies for Studying NMDA Receptor Protein Expression and Synapse-Specific Immunolabeling
4. Detecting Gastrin-Releasing Peptide Receptor by in situ PCR on Archived Tissue
5. pFB-ERV: Retroviral Delivery of the Ecdysone Receptor Proteins
6. Gene-Specific Primers for NMDA Receptor Subunits
7. TKB1 Cells Identify Receptor Tyrosine Kinase Interacting Proteins
8. Quantification of the Purinergic Receptor P2X3 using ICAT and Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer
9. Isolation of Low Molecular Weight Digestion Products of the Human Platelet Thromboxane A2 Receptor, Rev A
10. Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system
11. Use of FlashPlate Technology for In Vitro Measurement of [35S]-GTPγS Binding in CHO Cells Expressing the Human 5-HT1B Receptor

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: coupled Receptor Assays Using FLEXstation

(Date:11/5/2009)... Transgenomic, Inc. (OTC ...sults for the quarter ended September 30, 2009. Th... tables that follow. ,, Third Quarter 2009 ,... $0.01 per share for the third quarter of 2009 as ...are for the third quarter of 2008. ,, Net sale...
(Date:11/5/2009)...ber 5, 2009 Senomyx, Inc...prietary taste receptor-based technologies to disc...ge, and ingredient supply industries, today provid...ts for the third quarter ended September 30, 2009.... of 2009, compared to $4.0 million for the third q...
(Date:11/5/2009)...Drug safety specialty firm BioSoteria announced th... earned the Certified Professional in Learning and...rican Society for Training and Development (ASTD) ...e than fifteen years of medical communications and...e for the development of the company,s online phar...
(Date:11/4/2009)...The Human Anthrax Vaccine Program must be stopped....re film "A Call to Arms:2009 Edition" an...Immunity: The Human Anthrax Vaccine Story" to...ger of top secret government science turned into f...ility to its victims. It is available for world-w...
Breaking Biology Technology:Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7
...Presented at American Society for Metabolic and Ba...ting, SAN CLEMENTE, Calif., June 23 USGI Medical...presented clinical evidence showing,that its EndoS...s and,physicians to use an incisionless technique ...in patients who,ve regained weight after initial,s...
...PRING, Md. and SOUTH SAN FRANCISCO, Calif., June 2...d Actelion,Pharmaceuticals US, Inc. today announce...l PHA Award of Excellence in Pulmonary Arterial,Hy... $50,000, will be,awarded to an institution of Dr....llence in care for patients with PAH. The award, s...
...ion to enhance industry leader,s dermatological po...oratories Inc.,the world,s largest independent pha...oday announced it has signed a definitive merger a...ll acquire Barrier Therapeutics,Inc. ("Barrier The...ransaction, a tender offer followed by a merger of...
Other Biology Technology:Studies Show USGI Medical's EndoSurgical Operating System(TM) Enables Incisionless Surgery to Reduce Gastric Pouch and Stoma After Gastric Bypass 2Pulmonary Hypertension Association Names Recipient of 2008 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care 2Pulmonary Hypertension Association Names Recipient of 2008 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care 3Pulmonary Hypertension Association Names Recipient of 2008 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care 4Barrier Therapeutics to Merge Into Stiefel Laboratories 2Barrier Therapeutics to Merge Into Stiefel Laboratories 3Barrier Therapeutics to Merge Into Stiefel Laboratories 4Barrier Therapeutics to Merge Into Stiefel Laboratories 5
(Date:11/5/2009)...of Biology Teachers (NABT) will recognize Leonard ...Naugatuck Valley Community College (NVCC) in Water...on Award during the NABT annual professional devel...n Denver, Colorado. , The Evolution Education Aw...ological Sciences,(AIBS) and Biological Sciences ...
(Date:11/5/2009)... been awarded a training grant in the amount of $2...its Integrative Graduation Education and Research ...grant to be awarded to Kent State. The grant, whic...stment Act of 2009, runs through 2014. , The gra...ent aquatic resource sensing (EARS). The purpose o...
(Date:11/4/2009)...tural science) , United States Using Less Wate...ay than it did 35 years ago, despite a 30 percent ...tly attributable to alternative cooling methods at...s. According to the latest USGS water use report, ... goes to cooling thermoelectric power plants. Irri...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing 13384 1BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing 13384 2BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing 13384 3Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 1Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 2Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 3Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 4While Some New Agents Will Achieve Strong Sales the Migraine Drug Market Will Decline 241 3 Billion by 2018 as Generic Erosion Takes Toll on Top Sel 53712 1While Some New Agents Will Achieve Strong Sales the Migraine Drug Market Will Decline 241 3 Billion by 2018 as Generic Erosion Takes Toll on Top Sel 53712 2While Some New Agents Will Achieve Strong Sales the Migraine Drug Market Will Decline 241 3 Billion by 2018 as Generic Erosion Takes Toll on Top Sel 53712 3
...ids are synthetic hormones derived from the human ... been suspected in professional baseball and other...n endurance, is paramount. Power lifting is such a...act of anabolic steroid use on power lifters years...The researchers found that while physical traces o...
...udget was launched simultaneously by Global Carbon... Paris Observatory, and in the USA at Capitol Hill...l. , The Global Carbon Project posted the most re...to understanding the balance of carbon added to th...imate change. Despite the increasing international...
..., 2008 -Microbiologically contaminated water plagu...eri-urban populations in developing countries. Rou...nking water die each year from the consumption of ...5 years of age. , A new article published in Cu... instructions for constructing and using low-cost ...
Other Biology News:Anabolic steroids provide a competitive edge in power lifting years after doping has ended 2Anabolic steroids provide a competitive edge in power lifting years after doping has ended 3Growth in the global carbon budget 2
...TI-RNase is a protein ribonuclease inhibitor that ...atic RNase A-type enzymes. No inhibition is seen w...is distinct from human placental ribonuclease inhi...h RNase and does not release active RNase in the a...
RNaseOUT Recombinant Ribonuclease Inhibitor from Invitrogen
...e ChIP (Chemical Inkjet Printer) is a revolutionar...Protein Macroarray Analysis, developed in conjunct...ms. The strategy compliments established protocols...eins isoelectric point and apparent molecular weig...
...tural and Recombinant RNasin Ribonuclease Inhibito..., including the inhibition of eukaryotic RNases of...s inhibitory effect by noncovalently binding to RN...of RNasin Ribonuclease Inhibitor to RNase (e.g., R...
Biology Products: